Semnur Pharmaceuticals, Inc. (SMNR)

0.45 -0.01 (-2.17%) USD  |  OTCM  |  Sep 18, 16:00
More

Semnur Pharmaceuticals Cash from Investing (Quarterly) : 0.00 for June 30, 2026

Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for SMNR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 -2.335M
September 30, 2025 -6.283M
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 -3.485M
September 30, 2024 3.485M
June 30, 2024 0.00
Date Value
March 31, 2024 0.00
December 31, 2023 40.54M
September 30, 2023 0.00
June 30, 2023 -0.825M
March 31, 2023 0.00
December 31, 2022 -84.15M
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Scilex Holding Co. 8.452M
ANI Pharmaceuticals, Inc. -3.054M
Corcept Therapeutics, Inc. -29.24M
Veru, Inc. 1.802M
Johnson & Johnson -1.11B

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly) -2.138M
Cash from Financing (Quarterly) 2.074M
Free Cash Flow -10.49M
Free Cash Flow Per Share (Quarterly) -0.0093
Free Cash Flow to Equity (Quarterly) -5.507M
Free Cash Flow to Firm (Quarterly) -2.015M
Free Cash Flow Yield -10.45%